Seeking Alpha

Amyris and BASF to partner on R&D

  • Usually announcements like this don't move the needle much but shares of Amyris (AMRS +15.6%) are up nicely this morning in apparent response to its collaboration with BASF.
  • The company will use its synthetic biology and strain engineering platform to develop a microorganism capable of producing a BASF-targeted molecule.
  • No financial terms are disclosed.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector